FDA approves Vivus's fast-acting Viagra rival

NEW YORK (Reuters) - Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus Inc won U.S. approval for avanafil, its faster acting rival to Viagra.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/s09XbZrtF0Q/us-vivus-fda-idUSBRE83Q12L20120427

top news recent news save money travel make money best news